Company's Booth Spotlights Comprehensive Hip Portfolio and Enabling Technologies Including OrthoGrid Hip AI ® and HAMMRTM Automated Hip Impaction System WARSAW, Ind. , Oct. 28, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.
(NYSE and SIX: ZBH), a global medical technology leader, today announced plans for the broad commercial launch of the Z1TM Femoral Hip System (Z1 System) for total hip arthroplasty at the 2024 annual meeting of the American Association of Hip and Knee Surgeons (AAHKS). The highly-anticipated Z1 Femoral Hip System, a triple-taper femoral system, pairs with the Company's industry-leading G7 ® Acetabular System to provide surgeons with a versatile, streamlined and efficient total hip arthroplasty solution. At the meeting, being held November 7-10 in Dallas , positive data on the safety and durability of the G7 Acetabular System will be presented during the poster sessions.
"We are excited to share our robust hip portfolio, anchored by our new triple-taper femoral stem, Z1, and our well-established G7 Acetabular System," said Ivan Tornos, President and Chief Executive Officer of Zimmer Biomet. "Through a series of strategic acquisitions and in-house innovations, we've curated a diversified portfolio of hip implant solutions and innovative enabling technologies that provide surgeons with a wide array of options designed to address efficiency, accuracy and customization with a goal to improve overall surgical outcomes for patients." The Z1 System is tapered.